A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Clinical trial NCT01277692 · COMPLETED
Trial details
- NCT number
- NCT01277692
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-03
- Primary completion
- 2011-05-09
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.